SD

Suresh Datwan

Director Director DIN 01158271
DIN 01158271 First appointment Jul 1996 Primary industry General Business
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 0 active board seats
Past companies 1 historical roles
Total affiliations 1 Since Jul 1996
Shareholding value Locked Premium profile

About Suresh Datwan

Data last updated:

Suresh Datwan has 30 years in corporate governance. Formerly with 1 company, such as Umasons Pharma Private Limited. Engaged in General Business. Contributes to corporate operations.

DIN 01158271
Primary Designation Director
First Appointment 02 Jul 1996
Oldest Company Age Not Provided

Current companies

No current companies available.

Previous companies

CompanyDesignationAppointmentFoundedStatus
Umasons Pharma Private Limited U24232RJ1996PTC012282
Director02 Jul 19961996Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Umasons Pharma Private Limited
Premium access

Shareholding and investment profile for Suresh Datwan

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Suresh Datwan

Suresh Datwan has 30 years in corporate governance. Formerly with 1 company, such as Umasons Pharma Private Limited. Engaged in General Business. Contributes to corporate operations.

Suresh Datwan is associated with 0 companies as a director.

Suresh Datwan has expertise in General Business.

Suresh Datwan has 30 years in corporate governance.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available